Hair & Nails
Latest News
Topical or intralesional cidofovir an option for recalcitrant warts
Some studies have suggested that one in three children in primary school suffers from warts.
Latest News
Treating nail psoriasis: Intralesional injections and biologics
When Dr. Armstrong performs intramatricial injections, she uses triamcinolone acetonide at 10 mg/mL.
Latest News
Treatment of several nail disorders reviewed
Treatment with topical beta-blockers can be effective for pyogenic granuloma of the nail, and avoids the scarring seen with surgical removal,...
Pediatric Dermatology Consult
A toddler presents with a dark line on a fingernail
A 2-year-old boy presents with a dark band across a fingernail.
Latest News
Manicure gone wrong leads to cancer diagnosis
She put antibiotic ointment on the cut, but it didn't heal after a few days. Eventually, the skin closed and a darkened bump formed.
Latest News
Do collagen supplements benefit the skin?
“Maybe there’s some benefit, but the digestive process breaks collagen down into amino acids,” Dr. Ava Shamban said.
Commentary
Alopecia Areata in Skin of Color Patients: New Considerations Sparked by the Approval of Baricitinib
With the dawn of a new era in the treatment of alopecia areata (AA) as well as new information showcasing an altered prevalence of AA in skin of...
Latest News
Oral minoxidil improves anticancer treatment–induced alopecia in women with breast cancer
Oral minoxidil has been receiving increased attention as an adjunctive therapy for hair loss, particularly for women.
Latest News
Study evaluates features of alopecia areata in Hispanic/Latinx patients
The authors found that 18% of patients had one or more coexisting autoimmune conditions, most commonly rheumatoid arthritis and thyroid disease....
Aesthetic Dermatology Update
Hair supplements
Another point to consider before beginning supplementation is to educate patients about potential effects of supplementation, including increased...
Latest News
Current alopecia areata options include old and new therapies
Two oral JAK inhibitors in the pipeline for AA are deuruxolitinib and ritlecitinib, which significantly increased the proportion of patients...